Gene · 6359
CCL15: C-C motif chemokine ligand 15
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CCL15: C-C motif chemokine ligand 15. Genes, record 6359. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6359
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q16663 | C-C motif chemokine 15 | 113 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents65
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 18602 | Q16663 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 2128 | Q16663 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 18602 | Q16663 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 2128 | Q16663 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 2128 | Q16663 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 2135 | Q16663 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 12736 | Q16663 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 12737 | Q16663 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 14590 | Q16663 | Espacenet |
| US 11339436 B2 | 2022-05-24 | 1820 | Q16663 | Espacenet |
1 to 10 of 65
See all 65 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants857
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CCL15 papers | Newest fiscal year |
|---|---|---|---|
| UL1TR001863 | Yale Clinical and Translational Science Award | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 3 | 2025 |
| P30CA124435 | Stanford Cancer Institute | 3 | 2025 |
| P30DK036836 | Diabetes Research Center | 3 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 3 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| P30DK034989 | Yale Liver Center | 2 | 2025 |
1 to 10 of 857Source NIH's project files
See all 857 nih grantsPapers1,379
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of IL4I1+ M2-like macrophages in tumor microenvironment with poor prognosis in hepatocellular carcinoma: insights from bioinformatics and experimental validation. | Front Immunol | 2026 | 42495641 | PubTator, text mining | PubMed |
| Characterization of the plasma proteomic profile of dual trajectories in cognitive status and physical performance. | Geroscience | 2026 | 42301613 | PubTator, text mining | PubMed |
| Cytokines released by human tumors are independent from cancer histotype. | Eur J Cancer | 2026 | 42275854 | PubTator, text mining | PubMed |
| Characterization of a transmembrane-activating STING agonist using genetically humanized mice. | Cell Rep | 2026 | 42228573 | PubTator, text mining | PubMed |
| Nonlinear Modeling Reveals Novel Associations Between Genetically Predicted Protein Levels and Pancreatic Cancer Risk. | Mol Carcinog | 2026 | 42226484 | PubTator, text mining | PubMed |
| [Effects of immunological and metabolic parameters on the patient's functional outcome in the acute period of ischemic stroke]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2026 | 41943958 | PubTator, text mining | PubMed |
| Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma. | PLoS One | 2026 | 41838687 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization implicates causal plasma proteins in epilepsy. | Clin Neurol Neurosurg | 2026 | 41791135 | PubTator, text mining | PubMed |
| The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion. | Hepatology | 2026 | 41779954 | PubTator, text mining | PubMed |
| The Role of Rarely Studied Chemokines in Tumor Progression in Multiple Myeloma (MM). | Cancers (Basel) | 2026 | 41749925 | PubTator, text mining | PubMed |
1 to 10 of 1,379
See all 1,379 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6359
GET https://conductscience.org/api/genes/v1/6359/patents?page=2